Publications by authors named "Raphael C Cheung"

Claim this Profile
E
Effect of rosuvastatin on hepatic production of apolipoprotein B-containing lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia.
Taryne Chong, Mark Naples, Lisa Federico, Denise Taylor, Graham J Smith, Raphael C Cheung

Atherosclerosis· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of switching statins on lipid and apolipoprotein ratios in the MERCURY I study.
Raphael C Cheung, Jonathan M Morrell, David Kallend, Claire Watkins, Herbert Schuster

Int J Cardiol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.
Herbert Schuster, Philip J Barter, Steen Stender, Raphael C Cheung, Jacques Bonnet

Am Heart J· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simvastatin, an HMG-CoA reductase inhibitor, induces the synthesis and secretion of apolipoprotein AI in HepG2 cells and primary hamster hepatocytes.
Victoria Bonn, Raphael C Cheung, Biao Chen, Changiz Taghibiglou, Stephen C Van Iderstine

Atherosclerosis· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with atorvastatin ameliorates hepatic very-low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepatic insulin sensitivity.
Leyla Mangaloglu, Raphael C Cheung, Stephen C Van Iderstine, Changiz Taghibiglou, Louisa Pontrelli

Metabolism· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes.
Louisa Pontrelli, Wendy Parris, Khosrow Adeli, Raphael C Cheung

Metabolism· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis